{"id":"W2242665894","doi":"10.1200/jco.2009.27.15_suppl.8108","title":"An open label phase II trial of the Plk1 inhibitor BI 2536, in patients with sensitive relapse small cell lung cancer (SCLC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Progressive disease; Chemotherapy; Phases of clinical research; Gastroenterology; Oncology; Surgery; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001013721,0.001406997,0.00171385,0.0004090325,0.000489954,0.0007967406,0.0006479069,0.0009087767,0.004606169],"category_scores_gemma":[0.000656011,0.0005364011,0.0007306419,0.0003872051,0.0009257121,0.0008606718,0.0003686722,0.00244166,0.001283381],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006837063,"about_ca_system_score_gemma":0.001324473,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008661188,"about_ca_topic_score_gemma":0.002127024,"domain_scores_codex":[0.9997186,0.0001289603,0.00001867056,0.0000533475,0.00002469354,0.00005570042],"domain_scores_gemma":[0.999493,0.00008279735,0.0001006161,0.0000422706,0.00002929658,0.0002520448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7687394,0.07893934,0.008190866,0.0007137237,0.0005436167,0.0005665466,0.0003413315,0.001992039,0.05208467,0.0002198342,0.002947556,0.08472112],"study_design_scores_gemma":[0.4419269,0.5424557,0.0103109,0.00002492373,0.000177884,0.0003328922,0.00006076906,0.001083746,0.002331541,0.0001362537,0.001138178,0.00002035171],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955572,0.0007498047,0.0002934379,0.000168189,0.00005356622,0.001611728,0.0004749954,0.0000654349,0.001025571],"genre_scores_gemma":[0.9919077,0.0008081385,0.001099643,0.0004573875,0.0001158787,0.002181381,0.001482319,0.00001916825,0.00192833],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004606169,"threshold_uncertainty_score":0.01540911,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1210836524161229,"score_gpt":0.5261446769068916,"score_spread":0.4050610244907686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}